Dhruv Jani sells 10L Global Longlife shares, stake drops to 6.89%

1 min read     Updated on 10 Aug 2026, 11:59 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Dhruv Sureshkumar Jani, a promoter of Global Longlife Hospital and Research Limited, sold 10,00,000 equity shares on the BSE between August 06 and August 07, 2026. His stake decreased from 16.41% to 6.89%. The transaction was disclosed under SEBI Regulation 29(2) on August 08, 2026.

powered bylight_fuzz_icon
47888981

*this image is generated using AI for illustrative purposes only.

Promoter Dhruv Sureshkumar Jani has significantly reduced his stake in Global Longlife Hospital and Research Limited , selling 10,00,000 equity shares through open market transactions. The sale, which took place between August 06, 2026, and August 07, 2026, brings his total holding down from 16.41% to 6.89% of the company’s voting capital. This disclosure was made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, notifying the Bombay Stock Exchange of the change in shareholding pattern.

The transaction represents a substantial reduction in promoter ownership, with the sale accounting for 9.52% of the total diluted share and voting capital. Prior to the sale, Jani held 17,22,990 shares carrying voting rights. Following the disposal, his remaining holding stands at 7,22,990 shares. The company’s total equity share capital remains unchanged at ₹10,50,00,000, comprising 1,05,00,000 equity shares of ₹10 each.

Transaction Details

The following table outlines the change in shareholding before and after the sale:

Metric Before Sale Shares Sold After Sale
Shares with voting rights 17,22,990 10,00,000 7,22,990
Stake percentage 16.41% 9.52% 6.89%

Jani, who is part of the promoter group, executed the sales via the open market mechanism. No voting rights were acquired or sold otherwise than by shares, and there were no warrants, convertible securities, or other instruments entitling the seller to receive shares carrying voting rights involved in this transaction. Similarly, no shares were encumbered by pledge, lien, or non-disposal undertaking at the time of filing.

Regulatory Compliance

The disclosure was submitted to BSE Limited on August 08, 2026, adhering to the mandatory reporting requirements for substantial shareholders. The filing confirms that the seller belongs to the promoter/promoter group and lists the specific dates of acquisition and sale as August 06, 2026, to August 07, 2026. The company’s total diluted share/voting capital after the sale is not applicable, as indicated in the regulatory format. This reduction in promoter stake may be monitored by investors for potential implications on corporate governance and control dynamics within the organization.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
-4.98%+5.90%+18.91%-8.36%-43.30%-90.85%

What strategic reasons might drive promoter Dhruv Sureshkumar Jani to reduce his stake from 16.41% to 6.89% in such a short timeframe?

How could this significant drop in promoter holding impact investor confidence and the stock price of Global Longlife Hospital and Research Limited?

Does the reduction in stake below 10% trigger any changes in corporate governance requirements or control dynamics for the company?

Global Longlife Hospital & Research
View Company Insights
View All News
like18
dislike

Dhruv Jani sells 6,78,000 Global Longlife shares, stake drops to 16.41%

1 min read     Updated on 03 Aug 2026, 12:42 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Dhruv Sureshkumar Jani sold 6,78,000 shares of Global Longlife Hospital and Research Ltd via open market trades in July 2026. His promoter stake fell from 22.87% to 16.41%. The disclosure was filed under SEBI Regulation 29(2) on August 1, 2026.

powered bylight_fuzz_icon
47286748

*this image is generated using AI for illustrative purposes only.

Promoter Dhruv Sureshkumar Jani has reduced his stake in Global Longlife Hospital and Research by selling 6,78,000 equity shares on the open market. The sales, executed between July 01, 2026, and July 30, 2026, lower his holding from 22.87% to 16.41%, marking a significant dilution in promoter ownership during the month.

The disclosure was filed with BSE Limited on August 01, 2026, under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that the seller belongs to the promoter group and that the transactions were conducted via the open market rather than through block deals or off-market transfers.

Transaction Details

The sale represents a reduction of 6.46% in the company's total share capital. Prior to the transaction, Jani held 24,00,990 voting rights, which constituted 22.87% of the total diluted share/voting capital. Following the sale, his holding stands at 17,22,990 shares, representing 16.41% of the total capital.

Metric Before Sale Sale Details After Sale
Shares Held 24,00,990 6,78,000 17,22,990
Stake (%) 22.87% 6.46% 16.41%
Mode N/A Open Market N/A

The company’s total equity share capital remains unchanged at ₹10,50,00,000, comprising 1,05,00,000 equity shares of ₹10 each. There were no changes in voting rights acquired or sold otherwise than by shares, nor any warrants or convertible securities involved in the transaction.

What the Numbers Show

The reduction in promoter stake from 22.87% to 16.41% is material, indicating a deliberate exit strategy or liquidity requirement by the promoter. With no encumbrances such as pledges or liens reported in the filing, the shares sold were unencumbered assets. The open market mode suggests the sales were likely executed in smaller tranches to minimize price impact, a common practice for substantial holdings.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
-4.98%+5.90%+18.91%-8.36%-43.30%-90.85%

What is the primary motivation behind Dhruv Sureshkumar Jani's significant stake reduction, and does it signal a lack of confidence in Global Longlife's future growth prospects?

How might this 6.46% dilution in promoter ownership impact the stock's liquidity and volatility in the short term, given the open market execution method?

Are there indications of new institutional or foreign investors acquiring these shares, and could this shift in shareholder structure influence corporate governance decisions?

Global Longlife Hospital & Research
View Company Insights
View All News
like20
dislike

More News on Global Longlife Hospital & Research

Must Read Next

Earnings

Wockhardt Q1 Results: Net Profit at 1.06B rupees vs Loss of 900M YoY 6 mins ago
no imag found
Windlas Biotech Q1 Results: Revenue rises to 2.5B rupees, EBITDA margin contracts to 10.75% YoY 7 mins ago
CMR Green Tech Q1 Results: Net Profit Rises to 614M Rupees YoY, Revenue Falls 7 mins ago

Stocks

Exicom Tele-Systems Expects Higher EV Sales, Plans to Double AC Line Capacity From Q3 36 mins ago
no imag found
Bharat Forge Co-MD Flags Ongoing Review of Global Manufacturing Strategy Amid Profitability Challenges 41 mins ago
1 Year Returns:-43.30%